If you have not seen the U.S. Department of Justice’s news release on the H. Lee Moffitt Cancer Center & Research Institute Hospital, in the past few months I urge you to read it and absorb what it means for your billing compliance in research. Moffit agreed to a $19.5 million dollar resolution of liability related to a self-disclosure of improper billing for clinical trial costs in January of this year. Voluntarily disclosing and fully cooperating with the government’s investigation resulted in a settlement both to Medicare and the state’s Medicaid plan.^[1]